Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
about
Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsLiver Cirrhosis: Evaluation, Nutritional Status, and Prognosis.Nutrition and metabolism in hepatocellular carcinomaMeta-analysis: oral or enteral nutritional supplementation in cirrhosisSupportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver functionSerum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C.Serum albumin level is a notable profiling factor for non-B, non-C hepatitis virus-related hepatocellular carcinoma: A data-mining analysis.An association between dietary habits and traffic accidents in patients with chronic liver disease: A data-mining analysis.Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease.Effect of psoas muscle mass after endoscopic therapy for patients with esophageal varicesProtein tolerance to standard and high protein meals in patients with liver cirrhosisEffects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study.Comparison of Prognostic Impact between the Child-Pugh Score and Skeletal Muscle Mass for Patients with Liver Cirrhosis.Impact of Virtual Touch Quantification in Acoustic Radiation Force Impulse for Skeletal Muscle Mass Loss in Chronic Liver DiseasesManagement of hepatic encephalopathy in the hospitalBranched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders.Alterations of the gut microbiome and metabolome in alcoholic liver diseasePrognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis.Diet-induced hyperinsulinemia differentially affects glucose and protein metabolism: a high-throughput metabolomic approach in rats.Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis.Branched-chain amino acid supplementation reduces oxidative stress and prolongs survival in rats with advanced liver cirrhosisBranched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.Bolus ingestion of individual branched-chain amino acids alters plasma amino acid profiles in young healthy menMetformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb mice.Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing micePlasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.Factors Associated With Protein-energy Malnutrition in Chronic Liver Disease: Analysis Using Indirect CalorimetryNutritional status assessment in cirrhotic patients after protein supplementation.Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study.Influence of insulin resistance on the development of hepatocellular carcinoma after antiviral treatment for non-cirrhotic patients with chronic hepatitis C.Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis.The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population.A targeted metabolomic protocol for short-chain fatty acids and branched-chain amino acids.Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistanceBranched-chain amino acids in liver diseases.Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases.Effect of branched-chain amino acids in patients receiving intervention for hepatocellular carcinomaInfectious burden and atherosclerosis: A clinical issue.Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma and future treatments for the poor responders.
P2860
Q26772302-F2D0E7FF-2F7F-4C9F-A21A-3FC0B3655FBBQ26780309-488D2E76-D3C3-4C59-B19C-DC33D8F4AAEDQ26862862-BFE8EB88-D540-49AC-BAA6-B389F8BCC9EAQ27002659-0C9E6F78-A8E2-4F3C-9CEA-AFED70DABB14Q28066295-01187C4E-47B6-4B93-AFEC-A0912AF2CFC0Q30375016-C3EC6D9C-BD2C-4DED-ADE1-57777F4149DCQ30652699-88C349B3-5BF0-429E-8E2B-7C6F2D92CA01Q31086510-74504F09-7D38-40BA-9C0D-78C93A83F86AQ33566874-8D349B56-7E21-4322-81A4-CB8EB37DCA8BQ33638900-90401F1C-05AA-41C2-8D03-3F7B2C05B8A9Q33672865-22D80B9D-565A-48AC-89B1-B1192590342FQ33706732-D932FD25-39F2-417E-84D5-27EAB76562F5Q33817993-5C69C5D1-7525-4E0A-8BDE-41142BC78DBAQ33852021-F5903350-E273-440D-83C1-584C0B459B5FQ33852130-278A323D-5B42-4CE0-991C-4C747C3B4993Q34028149-00B307EA-0585-4EB6-9EB7-AC05DF882D32Q34222287-6B5171A9-C755-4504-9436-952608CA91B3Q34508873-51048AEA-69F8-4673-87C1-D95F123855A3Q34549563-E2043A61-7BC3-4014-BCEE-0DD04FDBF470Q34555259-76A6ED00-E6DF-47CE-9F72-0AE2E72CF708Q34635693-6213352D-79A8-4C27-A10F-A715FFB3F8B0Q34922542-AE4DC9DE-4197-43AB-AE8F-611F5948A804Q35040709-98542AF1-47B2-4243-9527-3093AFC04C75Q35059080-9CFFC94C-488D-4392-B0BA-B7D65EEEC820Q35447135-11CD76BA-4834-4F9C-ABA2-32F563C75376Q35538324-EF9AD04D-17A4-4DC3-A063-BC476CE1EA86Q36075660-4664DB5E-BC58-40E0-9A4C-AB5868DB9E21Q36478110-659759D3-B070-4B2A-9986-07CA96E0D658Q36486465-C6B4E5FD-35C7-47DE-A229-B287CAD38F7BQ36535642-607E8923-4F21-4CFD-AD1E-E1B7355064D5Q36611684-2ACC6484-BEBE-4B9E-A1FD-4222CC6B77CDQ37001748-06020194-C245-4F0C-BA9E-94CC13A5CC21Q37125652-CAF22963-2303-47C1-AEC4-9AD7F5C1FEEFQ37130508-56F46D5B-2BCA-445D-ACB1-F35BC532B178Q37276989-B8AAD6AA-6C7A-4A8E-BA57-60747C8A71CFQ37334109-183B0C66-7C45-4019-B2E9-D801D85B8C47Q37453196-A5F6E338-6B46-444B-A48E-C71833826E4DQ37629692-30DAC475-8928-4676-BF87-B4ECB09B0DAAQ37843968-97C71ACD-401F-480D-832B-BAD39E183D9FQ37965882-9E6E17C8-FB3D-4E61-912B-9FBF9E88F7D4
P2860
Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
@en
Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
@nl
type
label
Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
@en
Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
@nl
prefLabel
Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
@en
Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
@nl
P2093
P2860
P356
P1433
P1476
Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
@en
P2093
Michael R Charlton
Michio Sata
Namiki Izumi
Takumi Kawaguchi
P2860
P304
P356
10.1002/HEP.24412
P407
P577
2011-06-23T00:00:00Z